show episodes
 
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
  continue reading
 
Artwork

1
MicrobeWorld Video (audio only)

American Society for Microbiology

Unsubscribe
Unsubscribe
Monthly
 
A video podcast by the American Society for Microbiology that highlights the latest in microbiology, life science and biotechnology news. ASM is composed of over 42,000 scientists and health professionals with the mission to advance the microbial sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide. For information about ASM and MicrobeWorld, visit us online at www. ...
  continue reading
 
Host Russ Altman, a professor of bioengineering, genetics, and medicine at Stanford, is your guide to the latest science and engineering breakthroughs. Join Russ and his guests as they explore cutting-edge advances that are shaping the future of everything from AI to health and renewable energy. Along the way, “The Future of Everything” delves into ethical implications to give listeners a well-rounded understanding of how new technologies and discoveries will impact society. Whether you’re a ...
  continue reading
 
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something ...
  continue reading
 
Artwork

1
CHI Podcasts

Cambridge Healthtech Podcasts

Unsubscribe
Unsubscribe
Monthly
 
The CHI Podcasts are produced by the Cambridge Healthtech Institute and offer in-depth interviews with research and business leaders from many facets of biotechnology.
  continue reading
 
Anna Kavanaugh hosts the weekly radio series, "Mad Science: The Genetic Crossroad." The program aims to raise awareness and provide education about genetically modified organisms (GMO), in the world food supply and the practices of the GM biotech industry. The series is dedicated to all issues surrounding GM foods, its usage and ramifications thereof. Anna is a writer, advocate, and founder of the (AKCF) Anna Kavanaugh Charitable Foundation. Her original novel, "The Cord of Callows," now an ...
  continue reading
 
Sounds of Science is a monthly podcast about beginnings: how a molecule becomes a drug, how a rodent elucidates a disease pathway, how a horseshoe crab morphs into an infection fighter. The podcast is produced by Eureka, the scientific blog of Charles River, a contract research organization for drug discovery and development. Tune in and begin the journey.
  continue reading
 
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
  continue reading
 
Artwork

1
Biologize

Phil Richardson

Unsubscribe
Unsubscribe
Monthly
 
Dr Phil Richardson explores how to solve complex problems in strategy, innovation and change management using business models created from biological systems. Based on 3.8 billion years of evolution biological systems can provide a unique, if not counterintuitive way of thinking differently. The approach has been successfully used in product and service development, creating new ways of working, improving collaboration and delivering disruptive change.
  continue reading
 
Loading …
show series
 
In 2013 a number of county ordinances sought to end the use of biotech crops on various Hawaiian islands. Hawaii's warm year-'round climate permits several corn seasons a year, so seed corn for the mainland is produced in these locations. However, these technologies are not appreciated by a subset of the population, who see these companies as poiso…
  continue reading
 
In 2013 a number of county ordinances sought to end the use of biotech crops on various Hawaiian islands. Hawaii's warm year-'round climate permits several corn seasons a year, so seed corn for the mainland is produced in these locations. However, these technologies are not appreciated by a subset of the population, who see these companies as poiso…
  continue reading
 
Today, we’re re-running a fascinating conversation with Sara Singer, a Stanford professor of medicine, and an expert on integrated healthcare. Anyone who’s had to navigate the healthcare system knows it’s extremely complex, and care can often feel disjointed or inefficient. In this episode, Sara highlights new technologies that could improve integr…
  continue reading
 
While there have been a parade of novel therapeutic modalities in recent years, many of them are constrained by delivery challenges. Vesigen Therapeutics is developing novel drug delivery technology known as ARMMs that can transport a wide range of therapeutic payloads directly into the cytoplasm of target cells. We spoke to Paulash Mohsen, CEO of …
  continue reading
 
Great products and ideas are everywhere, yet limited by the ability to actually produce them in needed quantitites. The technologies from Sunflower Therapeutics enable bioprocess applications throughout the globe in a deployable unit with a small footprint. Dr. Kerry Love describes the technology and it's applications, along with the philosophy of …
  continue reading
 
Great products and ideas are everywhere, yet limited by the ability to actually produce them in needed quantitites. The technologies from Sunflower Therapeutics enable bioprocess applications throughout the globe in a deployable unit with a small footprint. Dr. Kerry Love describes the technology and it's applications, along with the philosophy of …
  continue reading
 
Psychologist Judy Fan is an expert in how physical objects facilitate learning. In the classroom, these include pencils, pens, paper, and whiteboards. But in any learning situation, the physical world provides tools for learning and communicating, often trumping the speed and reach of today’s digital technologies. These objects are cognitive tools …
  continue reading
 
The body has a natural mechanism for breaking down and clearing proteins. Arvinas is among a group of companies that’s seeking to harness this mechanism for therapeutic purposes. It has platform technology that enables the development of targeted protein degraders to breakdown disease-causing proteins. Among the benefits of this approach is that it…
  continue reading
 
T-cells are a critical part of the adaptive immune system, actively targeting problematic invaders. From pathogens to cancers, T-cells seek and destroy potentially dangerous cells, and maintain a memory of their presence. In today's episode Dr. Nigel McCracken describes this part of the adaptive immune system and how Virax Biolabs is using speciali…
  continue reading
 
T-cells are a critical part of the adaptive immune system, actively targeting problematic invaders. From pathogens to cancers, T-cells seek and destroy potentially dangerous cells, and maintain a memory of their presence. In today's episode Dr. Nigel McCracken describes this part of the adaptive immune system and how Virax Biolabs is using speciali…
  continue reading
 
From witchcraft to shamans to those with schizophrenia, voices and visions have always been part of human experience and they have always intrigued anthropologist Tanya Luhrmann. She now studies how various cultures understand these mysterious mental phenomena. Luhrmann has observed and talked to hundreds who’ve experienced voices and visions and l…
  continue reading
 
The traditional approach to treating autoimmune disease has relied on ways to suppress the immune system. COUR Pharmaceuticals is developing first-in-class therapies that instead seek to reprogram the immune system to create antigen-specific tolerance. We spoke to COUR CEO John Puisis and COUR Vice President of Research Adam Elhofy, about how the c…
  continue reading
 
Disinformation clouds the public understanding of science, especially technology in agriculture and medicine. So when a leading journal publishes false information, academic experts have an obligation to help correct the process. This may be done via a variety of methods, but cordial and collegial discussion is the first step. When that fails, note…
  continue reading
 
Disinformation clouds the public understanding of science, especially technology in agriculture and medicine. So when a leading journal publishes false information, academic experts have an obligation to help correct the process. This may be done via a variety of methods, but cordial and collegial discussion is the first step. When that fails, note…
  continue reading
 
Whether you’re taking a summer road trip, planning a long plane ride, or simply enjoying walks in the warm weather, we want to take a moment to recommend to you a few recent episodes of The Future of Everything to listen to along the way. You’ll find a list of these episodes in the show notes, but as a brief preview we’ve got conversations on robot…
  continue reading
 
The next blockbuster drug may already be in production by bacteria within your body. Bacteria produce unique chemical compounds that are bioactive and may have great therapeutic potential, but this chemical space has largely not been mined. Empress Therapeutics, a Flagship Pioneering company, is searching for such molecules by exploring the genes o…
  continue reading
 
Alberto Salleo is an expert in the long, chain-like molecules known as polymers. The world relies on polymers and the most common are in plastics. Salleo is now working on a new generation of organic polymers made of Earth-abundant materials that could lead to flexible electronics that can biodegrade or be easily recycled. These polymers could be g…
  continue reading
 
In most cases, the immune system detects and destroys cells that could become cancerous every day. For cancer to ravage the body, it needs to evade the immune system by shutting off its response. SIRPant Immunotherapeutics is seeking to address cancer by activating and modifying a patient’s own macrophages to awaken the immune system to cancer. The…
  continue reading
 
Felicia Samuel has worked for Charles River for years, but recently the work she contributes to has taken on a new meaning. Her daughter will be part of a clinical trial to receive one of the brand new sickle cell treatments, with the potential to drastically change her own and her family's lives. She joins me to discuss the details of this amazing…
  continue reading
 
We have another best-of episode for you today. This one is a conversation with Irene Lo about the work she’s doing to study and leverage markets for social impact — think markets for public school assignments, or medical school residency matches. Irene reminds us that markets exist to help effectively allocate limited resources, and not all marketp…
  continue reading
 
As the founder of SynBioBeta, John Cumbers has long evangelized to investors, entrepreneurs, and forward-thinking industrialists about the emergence of the bioeconomy. Cumbers, however, wants to share his sense of wonder about molecular biology with a broader audience through his new venture, Biological Enlightenment Studios. His ambition is for th…
  continue reading
 
Wikipedia is the go-to source for many people when starting to research a subject. But is the information correct, or does the information even exist in Wikipedia at all? Susan Gerbic has been training people to edit Wikipedia pages through the Gorilla Skeptics of Wikipedia project. They have edited tens of thousands of pages with over 16 million v…
  continue reading
 
Wikipedia is the go-to source for many people when starting to research a subject. But is the information correct, or does the information even exist in Wikipedia at all? Susan Gerbic has been training people to edit Wikipedia pages through the Gorilla Skeptics of Wikipedia project. They have edited tens of thousands of pages with over 16 million v…
  continue reading
 
Jonathan Long is a biochemist who studies the chemicals produced during exercise. In Long’s world, “you always start with molecules,” which offer “clean handles” to understanding complex processes. His lab has identified a chemical produced in the digestive tract during exercise that can make a person stop eating. Long now studies this “gut-brain a…
  continue reading
 
Electronic health records are a rich source of real-world data that can provide insights into health and wellness. Neal Meropol, head of research oncology at Flatiron Health, said they not only have value as a research tool for retrospective studies, but can be a treasure trove of information for prospective studies as well. We spoke to Meropol abo…
  continue reading
 
Crop genetic engineering has focused primarily on large-acreage crops like corn. But what about the universe of specialty crops that tantalize consumers, things like blackberries or salad greens? Pairwise has used precision twists on gene editing to change specific traits in fruit and vegetable crops. Pairwise founder and CEO, Dr. Tom Adams, discus…
  continue reading
 
Crop genetic engineering has focused primarily on large-acreage crops like corn. But what about the universe of specialty crops that tantalize consumers, things like blackberries or salad greens? Pairwise has used precision twists on gene editing to change specific traits in fruit and vegetable crops. Pairwise founder and CEO, Dr. Tom Adams, discus…
  continue reading
 
We’re digging back into our archives with an episode with bioengineer Polly Fordyce. Polly studies the form and function of proteins. She refers to proteins as the “workhorses” that make things in the body happen, and her study of these molecules reveals a greater understanding of human life. We hope you’ll tune in to this conversation again, and e…
  continue reading
 
Earlier this year, Profluent announced it had edited the human genome with OpenCRISPR-1, the world’s first AI-created and open-source gene editor. Though the open-source aspect helped garner attention for Profluent, it also served as a demonstration of the company’s generative AI platform to create novel CRISPR gene editors. We spoke to Hilary Eato…
  continue reading
 
Chris Piech is a professor of computer science who studies how computers can help students learn. In comparing human- and computer-aided education, he says humans are great one-on-one, but AI is more consistent at grading and feedback. He and colleagues have created several generative AI grading apps to take advantage of these relative strengths, a…
  continue reading
 
About 500,000 people suffer from a spinal cord injury each year. Treatments can involve surgical procedures to stabilize the spine and physical rehabilitation, which can have limited benefits. There are currently no FDA-approved therapies that can promote repair and improve function following a spinal cord injury. NervGen Pharma is seeking to chang…
  continue reading
 
Today's episode marks the beginning of the 10th year of the Talking Biotech Podcast. To celebrate, Drs. Liza Dunn and Kevin Folta discuss the last decade of biotech breakthroughs and communications efforts, the fight against technology and the amazing progress in gene editing and human genetic therapies. Plus, what you can do to help the effort goi…
  continue reading
 
Today's episode marks the beginning of the 10th year of the Talking Biotech Podcast. To celebrate, Drs. Liza Dunn and Kevin Folta discuss the last decade of biotech breakthroughs and communications efforts, the fight against technology and the amazing progress in gene editing and human genetic therapies. Plus, what you can do to help the effort goi…
  continue reading
 
Guest Matt Abrahams is a master communicator who helps others overcome their fear of speaking — before live audiences, in small groups, or even one-on-one. His catchphrase, “Think Fast, Talk smart,” describes a mindset that, he says, is key to speaking well. Thinking fast is the ability to recognize and respond to patterns in order to talk smart — …
  continue reading
 
One of the challenges of treating neurodegenerative diseases is delivering therapies across the blood-brain barrier. Aliada Therapeutics is developing therapies that use its platform technology that enables the delivery of large molecules, like antibodies, across that barrier. Its lead program is in development to treat Alzheimer’s disease. We spok…
  continue reading
 
What if we could replace mouse model control groups with a virtual equivalent? What would that mean for drug development in terms of cost, time, and animal model reduction? To answer, I am joined by Charles River associate director Laura Lotfi and Guillemette Duchateau-Nguyen from F. Hoffmann-La Roche Ltd, Pharmaceutical Sciences - Roche Innovation…
  continue reading
 
Chronic inflammation goes hand-in-hand with many diseases, complicating symptoms and affecting routes of treatment. What is the molecular basis of inflammation, and can it be targeted by new drugs? Scientists have studied the molecular basis of the inflammatory response and have identified specific proteins that complex to initiate the response. Ne…
  continue reading
 
Chronic inflammation goes hand-in-hand with many diseases, complicating symptoms and affecting routes of treatment. What is the molecular basis of inflammation, and can it be targeted by new drugs? Scientists have studied the molecular basis of the inflammatory response and have identified specific proteins that complex to initiate the response. Ne…
  continue reading
 
We’re bringing you a timely best-of episode, given the recent advances in generative AI tools like ChatGPT. A couple years ago we interviewed Jeff Hancock, a Stanford professor of communication whose research explores the psychological and interpersonal processes at play when people communicate with each other and with computers. At the time of thi…
  continue reading
 
SalubrisBio, rather than shy away from complexity, embraces it. The company’s lead experimental therapy is an antibody fusion protein in development for both heart failure and the rare, neurodevelopmental condition amyotrophic lateral sclerosis. We spoke to Sam Murphy, CEO of SalubrisBio, about the challenges of pursuing complex diseases with compl…
  continue reading
 
Astrophysicist Risa Wechsler studies the evolution of the universe. She says that our understanding of how the universe formed and how it will change over time is changing as new technologies for seeing and measuring space come online, like a new high-resolution camera that can quickly map the full sky to see everything that moves, or new spectrogr…
  continue reading
 
Loading …

Quick Reference Guide